Home » Topics » Regulatory » Patents

Patents
RSS

Hokuriku discloses agents for urinary incontinence

April 2, 1997

Selective CB2 receptor agonists prepared by Merck Frosst

April 2, 1997

Novel antitumor agents from Universidad Complutense

April 2, 1997

Centocor describes peptide inhibitors of selectin binding

April 2, 1997

MS&D prepares antimigraine pyrrolo-pyridine derivatives

April 2, 1997

Endothelin antagonists from SmithKline Beecham

April 2, 1997

Wyeth-Ayerst describes antiinflammatory agents

April 2, 1997

Lilly continues to develop compounds for postmenopausal syndrome

April 2, 1997

Hypoglycemic/hypolipidemic agents from Sankyo

April 1, 1997

Wakunaga discloses angiotensin II antagonists

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...